Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells.

Manfroi B, Dang V D, Cuc B T, Jungmann A, Borzakian S, Tong Y, Beauvineau C, Dupuis L, Guffart E, Borst K, et al.

Immunity. 2026 Oct 13; 59(10):2738-2757.e15. PMID: 42838057. Abstract